QS-21

Quillaja saponin

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for QS-21, covering 2013-01-31 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants [Phase 1]

See pricing